Ocugen Inc

OCGNNASDAQ · USD
1.06USD0.00 (+2.92%)
129

Ocugen Inc (OCGN) Option Chain

As of September 18, 2026, Ocugen Inc is trading at $1.06, a +2.92% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 90.8%. IV Rank is 8%.

Read more

Tracking the OCGN option chain helps you see every strike and expiry on Ocugen Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Ocugen Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of OCGN options activity at a glance. Use our scanner to monitor the OCGN option chain in real time and filter for the OCGN options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For OCGN stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the OCGN option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where OCGN stock options are being actively traded and where they are not.

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD.

Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Ocugen Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen OCGN options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of OCGN stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile7.54% Subdued
  • Market cap (M$)359
  • 52 weeks high-61.03%
  • 52 weeks low9.28%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$12.08
    1039.62% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-04
  • P/E
  • Future P/E
  • EPS (ttm)-0.25
  • EPS growth next 5 years45.37%

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.18990-0.010.560.250.850.50-52.830.050.000.0501299.82
45.114632,5380.090.060.100.201.00-5.660.100.000.10365,05254.89
93.482,44610.050.000.051.50+41.510.400.500.440.0132,4546.52
99.622,58200.100.000.102.00+88.680.501.500.940.060640.38
99.981,04600.050.000.052.50+135.851.002.001.440.06010.02

As of September 18, 2026

Scan the full option chain in one place

Browse the full OCGN option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial